31744
5431
Tata India Pharma & Healthcare Fund Growth
21.41
5.46
12.96
-2.60
2.56
2.96
0.36
11.38
7
1.84
12.96
Tata India Pharma & Healthcare Fund (G)
1.84
12.96
1.19
3.5
5 Years
  • NAV

    30.97

    02 Jun 2026

  • 21.41%

    3Y CAGR returns

One click to compare funds with our smart tool—analyze returns & more! Compare
  • ₹ 100

    Min SIP
  • ₹ 5000

    Min Lumpsum
  • 2.08%

    Expense Ratio
  • 3

    Rating
  • 1,325 Cr

    Fund Size
  • 10 Years

    Fund Age

SIP Calculator

Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00
Yr
  • Invested Amount
  • ₹ 00
  • Wealth Gained
  • ₹ 00
  • Expected Amount
  • ₹ 00

Returns and Ranks ( as on 02 Jun 2026 )

  • 1Y Returns
  • 3Y Returns
  • 5Y Returns
  • MAX Returns
  • Trailing Returns
  • 5.46%
  • 21.41%
  • 12.96%
  • 11.38
  • 13.15Alpha
  • 4.86SD
  • 0.83Beta
  • 0.81Sharpe
  • Exit Load
  • 0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.
  • Tax implication
  • Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.
Low Low to
moderate
Moderate Moderately
High
High Very
High
  • Fund Name
  • Address :
  • 1903, B-Wing, Parinee Crescenzo, G-Block, Bandra Kurla Complex, Bandra East Mumbai - 400051
    • Contact :
    • +91022 62827777
    • Email ID :
    • service@tataamc.com
Mutual Fund by Category

Large Cap

  • Fund Name

Mid Cap

Multi Cap

ELSS

Focused

Sectoral / Thematic

Small Cap

Dividend Yield

Ultra Short Duration

Liquid Mutual

Gilt Mutual

Long Duration

Overnight Mutual

Floater Mutual

Arbitrage Mutual

Equity Savings Mutual

Aggressive Hybrid Mutual

FAQs

Tata India Pharma & Healthcare Fund Growth has delivered 11.71% since inception

The NAV of Tata India Pharma & Healthcare Fund Growth is ₹31.5869 as of 02 Jun 2026

The expense ratio of Tata India Pharma & Healthcare Fund Growth is 2.08 % as of 02 Jun 2026

The AUM of Tata India Pharma & Healthcare Fund Growth 1325.19 CR as of 02 Jun 2026

The minimum SIP amount of Tata India Pharma & Healthcare Fund Growth is 100

The top stock holdings of Tata India Pharma & Healthcare Fund Growth are

  1. Sun Pharma.Inds. - 9.87%
  2. Divi's Lab. - 5.92%
  3. Health.Global - 5.45%
  4. Abbott India - 5.37%
  5. Max Healthcare - 5.17%

The top sectors Tata India Pharma & Healthcare Fund Growth has invested in are

  1. - 0%

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form